Medi Assist Healthcare Services Reports Strong Q4 & FY26 Performance; Turns Debt-Free with ₹260.5 Cr Free Cash Position

4 min read     Updated on 11 May 2026, 01:44 AM
scanx
Reviewed by
Ashish TScanX News Team
AI Summary

Medi Assist Healthcare Services Limited reported consolidated total income of ₹923.2 Cr (+23.6% YoY) and operating revenue of ₹904.8 Cr (+25.1% YoY) for FY26, while turning debt-free with a free cash position of ₹260.5 Cr and net worth expanding to ₹852.4 Cr. The company processed 10.0 million Group and Retail claims and administered premiums of ₹25,923.2 Cr (+22.8% YoY), achieving a Group market share of 33.7% (+340 bps YoY). The AI-powered Technology segment delivered 91.9% YoY revenue growth, with MAven Guard identifying approximately ₹540 Cr in health insurance fraud. The Paramount integration progressed with 50%+ of PHS claims volume migrated to MAtrix as of April 2026, on track to become the primary processing engine by Q2FY27.

powered bylight_fuzz_icon
39989698

*this image is generated using AI for illustrative purposes only.

Medi Assist Healthcare Services Limited has released its investor presentation for Q4 and FY26, highlighting a year of robust financial growth, technology-led transformation, and significant balance sheet strengthening. The company turned debt-free during FY26, achieving a free cash position of ₹260.5 Cr, while delivering double-digit revenue growth across most business segments. Chief Executive Officer and Whole Time Director Satish Gidugu described FY26 as "a milestone year" marked by AI-powered platforms processing nearly one million claims every month with industry-leading automation and fraud detection.

Financial Highlights: Q4 and FY26

The company's consolidated financials for Q4 and full-year FY26 reflect consistent top-line momentum and improving profitability metrics. The following table summarises the key performance indicators:

Metric: Q4 FY26 YoY Change FY26 YoY Change
Total Income: ₹243.2 Cr +23.7% ₹923.2 Cr +23.6%
Operating Revenue: ₹242.0 Cr +28.1% ₹904.8 Cr +25.1%
EBITDA: ₹48.3 Cr +18.4% ₹174.6 Cr +13.3%
EBITDA Margin: 19.9% +132 bps QoQ 19.3% -201 bps YoY

The company reported a PAT of ₹89.3 Cr for FY26, compared to ₹91.6 Cr in FY25. Adjusted PAT, excluding exceptional items net of tax effect, stood at ₹68.8 Cr. Management has also provided a steady-state PAT estimate of ₹98.0 Cr, bridging from the reported figure through normalization adjustments including a DTL reversal of ₹32.0 Cr related to the Paramount acquisition, exceptional items of ₹11.5 Cr, and other normalization items totalling ₹23.1 Cr.

Balance Sheet and Key Financial Metrics

Medi Assist Healthcare's balance sheet saw material improvement in FY26, with the company eliminating its debt position of ₹150.1 Cr from FY25 to become fully debt-free. The following table presents key balance sheet metrics:

Parameter: FY26 FY25
Free Cash Position: ₹260.5 Cr ₹312.2 Cr
Net Worth: ₹852.4 Cr ₹552.2 Cr
Contract Liability: ₹280.2 Cr ₹238.0 Cr
Debt Position: Debt-free ₹150.1 Cr
Revenue per Avg Headcount (Annualised): ₹13.1 Lakh* ₹14.2 Lakh

*Including Paramount

Business Segment Performance

The Group segment remained the largest revenue contributor, accounting for 69.5% of total revenue (+11 bps), with revenue of ₹629.1 Cr (+25.3% YoY) and premiums managed of ₹23,104 Cr (+25.6% YoY). Group market share stood at 33.7% (+340 bps YoY), with PUM growth of 28.1% for Private and SAHI clients (+1,327 bps vs. industry) and 24.6% for PSU clients (+1,411 bps vs. industry). Corporate integrations expanded to 1,339 from 1,066, spanning a portfolio of approximately 11,000 corporates across 25+ sectors. Fraud savings in the Group segment reached approximately ₹369 Cr (+47.6% YoY).

The Retail segment reported revenue of ₹95.5 Cr (+10.9% YoY), with TPA model premiums managed at ₹2,818.8 Cr (+4.2% YoY). The Platform Model recorded a significant jump in premiums managed to ₹18,156 Cr (+4,527% YoY), with claims managed under the Platform Model reaching 520K (~200% YoY). The Government segment delivered revenue of ₹113.6 Cr (+42.6% YoY), contributing 12.6% to total revenue (+154 bps), servicing approximately 27 crore members across 13 states and 3 UTs with an active headcount of 2,764.

The International Benefits Administration segment reported revenue of ₹41.1 Cr (+11.9%), contributing 4.5% to total revenue (-54 bps). Retail lives grew to 953k (+~400%), supported by a technology partnership with a leading insurance broker in Southeast Asia providing access to over USD 50 Mn in premiums, and retail access to over 50% of travel premiums placed in India.

Technology and AI Platform Momentum

The Technology segment was a standout performer, with revenue growing 91.9% YoY to ₹21.7 Cr, contributing 2.4% to total revenue (+84 bps YoY). Approximately 109.3 lakh claims were processed on the MAtrix platform, including approximately 212k global claims. Key AI-driven operational highlights for FY26 include:

  • MAven Guard: Approximately ₹540 Cr in health insurance fraud identified (+38.5% YoY)
  • Raksha Prime: Approximately 322k patients experienced bill-free discharge across approximately 6,000 hospitals
  • Inpatient Cashless: 63% by volume cashless; preauthorization within 10 minutes at 90%+ and discharge within 30 minutes at 50%+
  • Inpatient Reimbursement: End-to-end TAT for payments improved to 7.41 days from 11.2 days; 91.8% of reimbursements processed within 1 day; approximately ₹370 Cr of fraud prevented
  • Outpatient Processing: 44.5% of OP claims processed in real-time cashless format; voice calls per claim reduced from 0.39 to 0.35 (10.3% reduction)
  • Paramount Integration: 50%+ of PHS claims volume migration to MAtrix completed as of April 2026, on track to become the primary processing engine by Q2FY27; slump transfer to Medi Assist TPA effective February 1, 2026

Overall, the company processed 10.0 million Group and Retail claims in FY26, comprising 2.2 million Cashless IP, 1.3 million Reimbursement IP, 2.7 million Cashless OP, and 3.8 million Reimbursement OP. Group and Retail premiums administered stood at ₹25,923.2 Cr (+22.8% YoY), with overall Group and Retail market share reaching 20.7% (+115 bps YoY).

Historical Stock Returns for Medi Assist Healthcare

1 Day5 Days1 Month6 Months1 Year5 Years
-0.23%+9.20%+10.86%-23.69%-13.10%-18.81%

With Medi Assist now debt-free and holding ₹260.5 Cr in free cash, what acquisition targets or strategic investments is the company likely to pursue to accelerate growth in FY27?

Given the Platform Model's explosive 4,527% YoY growth in premiums managed, how sustainable is this trajectory and could it eventually surpass the traditional TPA model as the primary revenue driver?

As the Paramount integration targets MAtrix as the primary processing engine by Q2FY27, what are the risks of integration disruptions and how might they impact EBITDA margins if the timeline slips?

like17
dislike

Medi Assist Healthcare Q4 EBITDA Rs. 483M; FY26 Results Ad Published Under Reg 47

9 min read     Updated on 10 May 2026, 03:47 PM
scanx
Reviewed by
Naman SScanX News Team
AI Summary

Medi Assist Healthcare Services reported Q4 FY26 EBITDA of Rs. 483M and consolidated FY26 revenue of Rs. 9,047.67M, with the Board recommending a final dividend of Rs. 2 per share. Newspaper advertisements of audited results were published on May 10, 2026 in Business Line and Navshakti under Regulation 47, alongside key corporate developments including the Paramount TPA acquisition and preferential allotment to MIT and 238 Plan Associates LLC.

powered bylight_fuzz_icon
39592700

*this image is generated using AI for illustrative purposes only.

Medi Assist Healthcare Services Limited's Board of Directors, at their meeting held on May 09, 2026, approved the audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026, pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The statutory audit was conducted by M/s. MSKA & Associates LLP, whose reports carry an unmodified opinion on both standalone and consolidated financial results. The Board meeting commenced at 02:30 p.m. IST and concluded at 05:30 p.m. IST. Subsequently, pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, newspaper advertisements providing an extract of the audited financial results for the quarter and year ended March 31, 2026 were published on May 10, 2026 in 'Business Line' (English Newspaper) and 'Navshakti' (Marathi Newspaper). The trading window for dealing in shares of the Company is closed from April 01, 2026 till May 11, 2026.

Consolidated Financial Performance

Medi Assist Healthcare Services posted consolidated revenue from operations of Rs. 9,047.67 million for the year ended March 31, 2026, compared to Rs. 7,233.21 million in the previous year. Total income for the year stood at Rs. 9,232.44 million against Rs. 7,470.78 million in the prior year. On a quarterly basis, Q4 EBITDA came in at Rs. 483 million versus Rs. 407 million in the same period last year, while the Q4 EBITDA margin stood at 19.94% compared to 21.60% in the year-ago quarter. The following table summarises the key consolidated financial metrics:

Metric: Q4 FY26 Q3 FY26 Q4 FY25 FY26 FY25
Revenue from Operations (Rs. mn): 2,419.86 2,396.78 1,888.72 9,047.67 7,233.21
Other Income (Rs. mn): 12.46 77.71 184.77 237.57
Total Income (Rs. mn): 2,432.32 1,966.43 9,232.44 7,470.78
Total Expenses (Rs. mn): 2,153.28 1,665.96 8,286.97 6,352.91
EBITDA (Rs. mn): 483.00 407.00
EBITDA Margin (%): 19.94 21.60
Net Profit before Tax, Exceptional Items (Rs. mn): 279.04 226.63 300.47 945.47 1,117.87
Net Profit before Tax, after Exceptional Items (Rs. mn): 279.04 84.68 300.47 803.52 1,117.87
Net Profit after Tax – Continuing Operations (Rs. mn): 544.77 41.36 216.33 893.11 916.01
Profit for the Period/Year (Rs. mn): 544.77 41.36 215.88 893.11 915.18
Total Comprehensive Income (Rs. mn): 520.85 66.29 196.83 919.84 892.84
Paid-up Equity Share Capital (Rs. mn): 373.05 372.29 352.61 373.05 352.61
Reserves (excl. Revaluation Reserve) (Rs. mn): 8,015.98 5,062.09
Basic EPS (Rs.) – Continuing & Discontinued Ops: 7.33 0.51 3.05 12.14 12.91
Diluted EPS (Rs.) – Continuing & Discontinued Ops: 7.33 0.51 3.04 12.14 12.85

Consolidated total assets as at March 31, 2026 stood at Rs. 13,724.62 million compared to Rs. 11,582.27 million as at March 31, 2025. Total equity increased to Rs. 8,524.00 million from Rs. 5,521.57 million. Net cash flows from operating activities for the year were Rs. 1,180.71 million, while net cash used in investing activities was Rs. (1,596.34) million, primarily reflecting the acquisition of Paramount Health Services & Insurance TPA Private Limited.

Standalone Financial Performance

On a standalone basis, Medi Assist Healthcare Services reported revenue from operations of Rs. 2,254.55 million for the year ended March 31, 2026, compared to Rs. 1,505.86 million in the prior year. The following table presents the key standalone financial metrics:

Metric: Q4 FY26 Q3 FY26 Q4 FY25 FY26 FY25
Revenue from Operations (Rs. mn): 635.63 574.28 425.53 2,254.55 1,505.86
Profit before Tax (before exceptional items) (Rs. mn): 193.99 157.51 147.90 688.18 445.54
Profit before Tax (after exceptional items) (Rs. mn): 193.99 156.99 147.90 687.66 445.54
Profit after Tax – Continuing Operations (Rs. mn): 144.97 118.33 107.31 519.86 332.08
Profit after Tax – Continuing & Discontinued Ops (Rs. mn): 144.97 118.33 107.31 519.86 332.08
Other Income (Rs. mn): 51.48 6.32 146.31 76.66
Total Income (Rs. mn): 687.11 431.85 2,400.86 1,582.52
Total Expenses (Rs. mn): 493.12 283.95 1,712.68 1,136.98
Total Comprehensive Income (Rs. mn): 137.74 101.57 515.99 325.11
Basic EPS (Rs.): 1.95 1.53 7.18 4.72
Diluted EPS (Rs.): 1.95 1.52 7.18 4.69

Standalone total assets as at March 31, 2026 stood at Rs. 5,502.91 million versus Rs. 3,311.16 million as at March 31, 2025. Total equity on a standalone basis rose to Rs. 4,893.88 million from Rs. 2,296.86 million.

Dividend Recommendation

The Board of Directors, at their meeting held on May 09, 2026, recommended a final dividend of Rs. 2 per equity share (face value Rs. 5 per share), representing 40% of face value, for the year ended March 31, 2026. The dividend is payable subject to approval by shareholders at the ensuing Annual General Meeting. The record date, as and when fixed, shall be intimated to the Stock Exchanges. Dividend shall be paid, subject to deduction of tax at source, within 30 days from the date of shareholders' approval at the ensuing AGM.

Key Corporate Developments

During the year, Medi Assist Healthcare Services completed the acquisition of 100% equity stake in Paramount Health Services and Insurance TPA Private Limited on July 01, 2025, upon payment of a purchase consideration of Rs. 4,124.40 million after closing adjustments. Paramount TPA consequently became a wholly-owned subsidiary of Medi Assist Insurance TPA Private Limited (MAITPA) and a step-down subsidiary of the Company. Additionally, on October 10, 2025, the Company allotted 37,01,000 fully paid-up equity shares at Rs. 535 per share via preferential allotment, raising an aggregate consideration of Rs. 1,980.03 million from Massachusetts Institute of Technology (28,90,830 shares; Rs. 1,546.59 million) and 238 Plan Associates LLC (8,10,170 shares; Rs. 433.44 million). As of March 31, 2026, Rs. 496.00 million of the net proceeds remained unspent. During the quarter ended March 31, 2026, the paid-up equity share capital of the Company increased from Rs. 352.61 millions to Rs. 373.05 millions, pursuant to exercise of stock options by certain employees and allotment of 385,863 equity shares and 3,701,000 equity shares by way of preferential allotment.

The consolidated results include exceptional items totalling Rs. 141.95 million for the year ended March 31, 2026, comprising: Rs. 37.68 million towards cyber-security incident costs at Paramount TPA; Rs. 33.27 million towards incremental employee benefit provisions under the New Labour Codes effective November 21, 2025; and Rs. 71.00 million towards a prudential provision made by MAITPA against advances paid to an insurance company customer pending reconciliation. Separately, on April 04, 2025, the Enforcement Directorate conducted a search and seizure operation at certain offices of MAITPA in Ranchi, Jharkhand. Management has assessed that there is no adverse impact on the Group from this matter, and no adjustment has been made in the financial results.

Other Board Decisions

Based on the recommendation of the Audit Committee, the Board approved the appointment of M/s. PricewaterhouseCoopers Services LLP as Internal Auditors of the Company for the financial year 2026-2027. PricewaterhouseCoopers Services LLP is among the leading professional services networks in the world, with more than 364,000 people in 136 countries and 137 territories, providing services across audit and assurance, tax and legal, deals and consulting. Additionally, based on the recommendation of the Nomination & Remuneration Committee, the Board reviewed certain positions operating at the group level and designated the following officials as Senior Managerial Personnel of the Company in accordance with the SEBI Listing Regulations:

Sr. No.: Name: Designation:
1. Ms. Vinaya Natarajan Chief Legal Officer
2. Mr. Praveen Samariya Chief Technology Officer
3. Mr. Dhruv Rastogi Chief AI Officer

Profiles of Newly Designated Senior Managerial Personnel

Ms. Vinaya Natarajan – Chief Legal Officer: Vinaya Natarajan holds a B.A., LLB (Hons) from the National Academy of Legal Studies and Research (NALSAR) and a Masters in Law from the University of London. She has over 17 years of experience in providing strategic, transactional and compliance-related support and advisory in-house to multinational companies. She has previously held senior positions with LTIMindtree, Tata Technologies, Genworks Health and the Hinduja Group.

Mr. Praveen Samariya – Chief Technology Officer: Praveen Samariya has more than 15 years of extensive experience in engineering and technology. He holds bachelor's and master's degrees in Computer Science and Engineering from the Indian Institute of Technology, Delhi. He has previously served as Head of Engineering at Mahindra Logistics, Co-Founder and CTO of AHA Taxis, and CTO and Director at SamayLa.

Mr. Dhruv Rastogi – Chief AI Officer: Dhruv Rastogi has over 16 years of experience across financial services, insurance, and marketing, operating at the intersection of business strategy, product innovation, and AI-led go-to-market execution within regulated enterprise environments. His career includes leading AI and Data Technology teams at Nomura, Edelweiss, Reliance Industries, Vodafone, Idea and IKS Health. He is an IIT Madras alumnus and has led numerous award-winning projects recognised for innovation and impact.

Earnings Call Details

Medi Assist Healthcare Services has scheduled an earnings call to discuss the audited financial results. The key details are as follows:

Parameter: Details:
Day/Date: Monday, May 11, 2026
Time: 08:30 am IST
India Dial-In: +91 22 6280 1131, +91 22 7115 8032
UK (Toll Free): 08081011573
USA (Toll Free): 18667462133
Singapore (Toll Free): 8001012045
Hong Kong (Toll Free): 800964448
Investor Relations Email: investor.relations@mediassist.in

The following senior management members will participate in the earnings call:

S.No.: Name: Designation:
1. Dr. Vikram Chhatwal Chairman and Whole-time Director
2. Mr. Satish Gidugu Chief Executive Officer and Whole-time Director
3. Mr. Sandeep Daga Chief Financial Officer

Participants are encouraged to pre-register for the call to connect without waiting for operator assistance. Upon registration, participants will receive dial-in numbers, a passcode, and a pin on their registered email address. The intimation has been signed by Rashmi B V, Company Secretary & Compliance Officer (ICSI Membership No: A38729), and is available on the Company's website at www.mediassist.in .

Historical Stock Returns for Medi Assist Healthcare

1 Day5 Days1 Month6 Months1 Year5 Years
-0.23%+9.20%+10.86%-23.69%-13.10%-18.81%

How will the full-year integration of Paramount TPA's operations impact Medi Assist's consolidated EBITDA margins in FY27, given the cybersecurity incident costs and pending reconciliation provisions that weighed on FY26 results?

With MIT and 238 Plan Associates as new institutional investors and Rs. 496 million in unspent preferential allotment proceeds, what strategic acquisitions or technology investments is Medi Assist likely to prioritize in the near term?

How might the appointment of a dedicated Chief AI Officer alongside a new CTO signal a shift in Medi Assist's competitive strategy within the TPA industry, and could AI-driven automation materially improve claims processing efficiency and margins?

like18
dislike

More News on Medi Assist Healthcare

1 Year Returns:-13.10%